Alkermes (ALKS) EBIAT (2016 - 2025)
Alkermes (ALKS) has disclosed EBIAT for 16 consecutive years, with $49.3 million as the latest value for Q4 2025.
- Quarterly EBIAT fell 66.14% to $49.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $241.7 million through Dec 2025, down 34.03% year-over-year, with the annual reading at $241.7 million for FY2025, 35.06% down from the prior year.
- EBIAT for Q4 2025 was $49.3 million at Alkermes, down from $82.8 million in the prior quarter.
- The five-year high for EBIAT was $237.1 million in Q2 2023, with the low at -$64.0 million in Q3 2022.
- Average EBIAT over 5 years is $46.5 million, with a median of $42.3 million recorded in 2023.
- The sharpest move saw EBIAT crashed 21532.84% in 2021, then skyrocketed 10995.19% in 2022.
- Over 5 years, EBIAT stood at $873000.0 in 2021, then surged by 10995.19% to $96.9 million in 2022, then skyrocketed by 65.76% to $160.6 million in 2023, then fell by 9.23% to $145.7 million in 2024, then crashed by 66.14% to $49.3 million in 2025.
- According to Business Quant data, EBIAT over the past three periods came in at $49.3 million, $82.8 million, and $87.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.